DBV Technologies | DBVT - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 459.28M 387K 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Galectin Therapeutics USD -83.87M 11.06M 2024-06
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12